A new resource developed at the Garvan Institute of Medical Research and The Kinghorn Cancer Center for oncologists could help make targeted cancer therapies more accessible for Australian patients.
Jun 24, 2021
0
6
Precision oncology has led to approved, molecularly specific, biomarker-defined indications for targeted therapies. With the number of validated drug targets increasing, testing each patient's tumor for all markers related ...
Apr 30, 2021
0
0
In a new study published in the journal AI in Precision Oncology, Nikhil Thaker, from Capital Health and Bayta Systems, and co-authors, evaluated the performance of various LLMs, including OpenAI's GPT-3.5-turbo, GPT-4, GPT-4-turbo, ...
Feb 8, 2024
0
0
